Gold nanocrystals as potential inhibitors of tumor angiogenesis: implications in diagnosis and drug delivery
Source abstract
Abstract
Angiogenesis is considered one of the hallmarks in tumor biology which contributes to metastasis and tumor progression by promoting the growth and development of blood vessels in order to supply nutrients and oxygen to the growing cancer cells. Numerous attempts have been made to target the mechanism of angiogenesis, out of which the most approachable method is the administration of angiogenesis inhibitors to target the growth of new blood vessels, which seems to be a powerful tool in targeted drug delivery when incorporated into nanocarriers and directed towards the tumor site. The main objective of this review is to focus on the importance of gold nanocrystals as an emerging tool in targeting tumor angiogenesis, and thereby facilitate tumor diagnosis and therapy. This review deals with the remarkable physicochemical and biological features of gold nanocrystals that make them ideal drug delivery systems. It gives an overview of the preclinical and clinical studies carried out using gold nanocrystals and also describes the recent advances in the applications of gold nanocrystals in tumor diagnosis, imaging, photodynamic therapy, and drug delivery, along with their limitations. Gold nanocrystals have proven to show promising effects in tumor-specific delivery of the drugs and are beneficial in reducing the undue effects on the surrounding normal cells and also in enhancing the intratumoral drug accumulation. Hence, they could be exploited as potential antiangiogenic agents and as targeted cancer therapeutics.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (80)
Show source-provided references
1. Adair TH, Montani JP (2010) Angiogenesis. Morgan and Claypool Life Sciences, Willston
2. Arvizo RR, Rana S, Miranda OR, Bhattacharya R, Rotello VM, Mukherjee P (2011) Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine 5:580–710.1016/j.nano.2011.01.011 ↗
3. Bayazit MK, Yue J, Cao E, Gavriilidis A, Tang J (2016) Controllable synthesis of gold nanoparticles in aqueous solution by microwave assisted flow chemistry. ACS Sustain Chem Eng 12:6435–6442. https://doi.org/10.1515/9783110345100-00410.1515/9783110345100-004 ↗
4. Bhattacharya R, Mukherjee P (2008) Biological properties of “naked” metal nanoparticles. Adv Drug Deliv Rev 60:1289–1306. https://doi.org/10.1016/j.addr.2008.03.01310.1016/j.addr.2008.03.013 ↗
5. Burda C, Chen X, Narayanan E-S (2005) Chemistry and properties of nanocrystals of different shapes. Chem Rev 105:1025–1102. https://doi.org/10.1021/cr030063a10.1021/cr030063a ↗
6. Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X, Xie C, Jiang K, Li J, Zhou J, Wang J (2019) Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma. ACS Nano 13:5591–5601. https://doi.org/10.1021/acsnano.9b0066110.1021/acsnano.9b00661 ↗
7. Chanda N, Upendran A, Boote EJ, Zambre A, Axiak S, Selting K, Katti KV, Leevy WM, Afrasiabi Z, Vimal J, Singh J (2014) Gold nanoparticle-based X-ray contrast agent for tumor imaging in mice and dog: a potential nanoplatform for computer tomography theranostics. J Biomed Nanotechnol 10:383–392. https://doi.org/10.1166/jbn.2014.172510.1166/jbn.2014.1725 ↗
8. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582–1584. https://doi.org/10.1126/science.752153910.1126/science.7521539 ↗
9. Danhier F, Feron O, Préat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–146. https://doi.org/10.1016/j.jconrel.2010.08.02710.1016/j.jconrel.2010.08.027 ↗
10. El-Kenawi AE, El-Remessy AB (2013) Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol 170:712–729. https://doi.org/10.1111/bph.1234410.1111/bph.12344 ↗
11. Fraisl P, Mazzone M, Schmidt T, Carmeliet P (2009) Regulation of angiogenesis by oxygen and metabolism. Dev Cell 16:167–17910.1016/j.devcel.2009.01.003 ↗
12. Freitas de Freitas L, Varca GH, dos Santos Batista JG, BenevoloLugao A (2018) An overview of the synthesis of gold nanoparticles using radiation technologies. Nanomaterials 11:939. https://doi.org/10.3390/nano811093910.3390/nano8110939 ↗
13. Gacche RN, Meshram RJ (2014) Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy. Biochim Biophys Acta Rev Cancer 1846:161–179. https://doi.org/10.1016/j.bbcan.2014.05.00210.1016/j.bbcan.2014.05.002 ↗
14. Goradel NH, Ghiyami-Hour F, Jahangiri S, Negahdari B, Sahebkar A, Masoudifar A, Mirzaei H (2018) Nanoparticles as new tools for inhibition of cancer angiogenesis. J Cell Physiol 233:2902–2910. https://doi.org/10.1002/jcp.2602910.1002/jcp.26029 ↗
15. Han X, Su R, Huang X, Wang Y, Kuang X, Zhou S, Liu H (2019) Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance. Asian J Pharm Sci 14:569–580. https://doi.org/10.1016/j.ajps.2018.06.00610.1016/j.ajps.2018.06.006 ↗
16. Harrison MR, Hahn NM, Pili R, Oh WK, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G (2011) A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Investig New Drugs 29:1465–1474. https://doi.org/10.1007/s10637-010-9455-xs10.1007/s10637-010-9455-xs ↗
17. Hashemi Goradel N, Ghiyami-Hour F, Jahangiri S, Negahdari B, Sahebkar A, Masoudifar A, Mirzaei H (2018) Nanoparticles as new tools for inhibition of cancer angiogenesis. J Cell Physiol 233:2902–2910. https://doi.org/10.1002/jcp.2602910.1002/jcp.26029 ↗
18. Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, Russell M, Boland P, Leidich R, Hylton D, Burova E, Ioffe E (2002) VEGF-Trap: a VEGF blocker with potent antitumor effects. PNAS 99:11393–11398. https://doi.org/10.1073/pnas.17239829910.1073/pnas.172398299 ↗
19. Huang X, El-Sayed MA (2010) Gold nanoparticles: Optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res 1:13–28. https://doi.org/10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
20. Huang MH, Lin PH (2012) Shape-controlled synthesis of polyhedral nanocrystals and their facet-dependent properties. Adv Funct Mater 1:14–24. https://doi.org/10.1002/adfm.20110178410.1002/adfm.201101784 ↗
21. Huang X, Peng X, Wang Y, Wang Y, Shin DM, El-Sayed MA, Nie S (2010) A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4:5887–5896. https://doi.org/10.1021/nn102055s10.1021/nn102055s ↗
22. Jain RK, Duda DG, Clark JW, Loeffler JS (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3:24–40. https://doi.org/10.1038/ncponc040310.1038/ncponc0403 ↗
23. Jang JT, Nah H, Lee JH, Moon SH, Kim MG, Cheon J (2009) Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew Chem Int Ed 48:1234–123810.1002/anie.200805149 ↗
24. Jarvis M, Krishnan V, Mitragotri S (2019) Nanocrystals: a perspective on translational research and clinical studies. Bioengineering Transl Med 4:5–16. https://doi.org/10.1002/btm2.1012210.1002/btm2.10122 ↗
25. Kerbel RS (2008) Tumor Angiogenesis. New Engl J Med 358:2039–2049. https://doi.org/10.1056/NEJMra070659610.1056/NEJMra0706596 ↗
26. Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2:727–739. https://doi.org/10.1038/nrc90510.1038/nrc905 ↗
27. MsY Khan, Roy M (2019) Synthesis, limitation and application of gold nanoparticles in treatment of cancerous cell. Int J Sci Res Multidiscip Stud 1:5–9
28. Khan AK, Rashid R, Murtaza G, Zahra A (2014) Gold nanoparticles: synthesis and applications in drug delivery. Trop J Pharm Res 7:1169–1177. https://doi.org/10.4314/tjpr.v13i7.2310.4314/tjpr.v13i7.23 ↗
29. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841–844. https://doi.org/10.1038/362841a010.1038/362841a0 ↗
30. Kim F, Connor S, Song H, Kuykendall T, Yang P (2004) Platonic Gold Nanocrystals. Angew Chem Int 43:3673–3677. https://doi.org/10.1002/anie.20045421610.1002/anie.200454216 ↗
31. Klagsbrun MDAP, D’amore PA (1991) Regulators of angiogenesis. Ann Rev Physiol 53:217–239. https://doi.org/10.1146/annurev.ph.53.030191.00124510.1146/annurev.ph.53.030191.001245 ↗
32. Kudgus RA, Bhattacharya R, Mukherjee P (2011) Cancer nanotechnology: emerging role of gold nanoconjugates. Anticancer Agents Med Chem 10(965):73. https://doi.org/10.2174/18715201179792765210.2174/187152011797927652 ↗
33. Lee N, Choi Y, Lee Y, Park M, Moon WK, Choi SH, Hyeon T (2012) Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r 2 relaxivity for highly sensitive in vivo MRI of tumors. Nano Lett 12:3127–3131. https://doi.org/10.1021/nl301030810.1021/nl3010308 ↗
34. Li W, Zhao X, Du B, Li X, Liu S, Yang XY, Yang W, Ding F, Pan X, Wu L, Qin, (2016) Gold nanoparticle–mediated targeted delivery of recombinant human endostatin normalizes tumour vasculature and improves cancer therapy. Sci Rep 6:30619. https://doi.org/10.1038/srep3061910.1038/srep30619 ↗
35. Link S, El-Sayed MA (2003) Optical properties and ultrafast dynamics of metallic nanocrystals. Ann Rev Phys 54:331–366. https://doi.org/10.1146/annurev.physchem.54.011002.10375910.1146/annurev.physchem.54.011002.103759 ↗
36. Liu D, Wu W, Ling J, Wen S, Gu N, Zhang X (2011) Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv Funct Mater 21:1498–1504. https://doi.org/10.1002/adfm.20100165810.1002/adfm.201001658 ↗
37. Lu Y, Li Y, Wu W (2016) Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B 6:106–113. https://doi.org/10.1016/j.apsb.2015.11.00510.1016/j.apsb.2015.11.005 ↗
38. Maeda H, Bharate GY, Daruwalla J (2009) Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 1:409–419. https://doi.org/10.1016/j.ejpb.2008.11.01010.1016/j.ejpb.2008.11.010 ↗
39. Menon D, Basanth A, Retnakumari A, Manzoor K, Nair SV (2012) Green synthesis of biocompatible gold nanocrystals with tunable surface plasmon resonance using garlic phytochemicals. J Biomed Nanotechnol 8:901–911. https://doi.org/10.1166/jbn.2012.145510.1166/jbn.2012.1455 ↗
40. Merisko-Liversidge E, Sarpotdar P, Bruno J, Hajj S, Wei L, Peltier N, Rake J, Shaw JM, Pugh S, Polin L, Jones J (1996) Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm Res 13:272–278. https://doi.org/10.1023/A:101605131681510.1023/A:1016051316815 ↗
41. Miao X, Yang W, Feng T, Lin J, Huang P (2018) Drug nanocrystals for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 10:1499. https://doi.org/10.1002/wnan.152710.1002/wnan.1527 ↗
42. Michalet X, Pinaud F, Lacoste TD, Dahan M, Bruchez MP, Alivisatos AP, Weiss S (2001) Properties of fluorescent semiconductor nanocrystals and their application to biological labeling. Single Mol 2:261–276. https://doi.org/10.1002/1438-5171(200112)2:4%3c261::AID-SIMO261%3e3.0.CO;2-P10.1002/1438-5171(200112)2:4<261::AID-SIMO261>3.0.CO;2-P ↗
43. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S (2005) Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 11:3530–3534. https://doi.org/10.1158/1078-0432.CCR-04-248210.1158/1078-0432.CCR-04-2482 ↗
44. Ntoutoume GMN, Granet R, Mbakidi JP, Brégier F, Léger DY, Fidanzi-Dugas C, Lequart V, Joly N, Liagre B, Chaleix V, Sol V (2016) Development of curcumin–cyclodextrin/cellulose nanocrystals complexes: new anticancer drug delivery systems. Bioorg Med Chem Lett 26:941–945. https://doi.org/10.1016/j.bmcl.2015.12.06010.1016/j.bmcl.2015.12.060 ↗
45. Pan Y, Wu Q, Qin L, Cai J, Du B (2014) Gold nanoparticles inhibit VEGF165-induced migration and tube formation of endothelial cells via the Akt pathway. Biomed Res Int 1:2014. https://doi.org/10.1155/2014/41862410.1155/2014/418624 ↗
46. Patel AR, Chougule MB, Lim E, Francis KP, Safe S, Singh M (2014) Theranostic tumor homing nanocarriers for the treatment of lung cancer. Nanomed Nanotechnol 10:1053–1063. https://doi.org/10.1016/j.nano.2013.12.00210.1016/j.nano.2013.12.002 ↗
47. Patra JK, Baek KH (2014) Green nanobiotechnology: factors affecting synthesis and characterization techniques. J Nanomater 1:2014. https://doi.org/10.1155/2014/41730510.1155/2014/417305 ↗
48. Patra JK, Das G, Fraceto LF, Campos EVR, del Pilar R-T, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16:71. https://doi.org/10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
49. Pawar VK, Singh Y, Meher JG, Gupta S, Chourasia MK (2014) Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release 183:51–66. https://doi.org/10.1016/j.jconrel.2014.03.03010.1016/j.jconrel.2014.03.030 ↗
50. Pedrosa P, Heuer-Jungemann A, Kanaras AG, Fernandes AR, Baptista PV (2017) Potentiating angiogenesis arrest in vivo via laser irradiation of peptide functionalised gold nanoparticles. J Nanobiotechnol 1:85. https://doi.org/10.1186/s12951-017-0321-210.1186/s12951-017-0321-2 ↗
51. Quesada AR, Medina MÁ, Alba E (2007) Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. Bioassays 29:1159–1168. https://doi.org/10.1002/bies.2065510.1002/bies.20655 ↗
52. Rabinow BE (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785–796. https://doi.org/10.1038/nrd149410.1038/nrd1494 ↗
53. Rahmathulla G, Hovey EJ, Hashemi-Sadraei N, Ahluwalia MS (2013) Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges. Onco Targets Ther 6:371. https://doi.org/10.2147/OTT.S3862810.2147/OTT.S38628 ↗
54. Rane AV, Kanny K, Abitha VK, Thomas S (2018) Methods for synthesis of nanoparticles and fabrication of nanocomposites. In: Bhagyaraj SM, Oluwafemi OS, Kalarikkal N, Thomas S (eds) Synthesis of Inorganic Nanomaterials. Woodhead publishing, UK, pp 121–13910.1016/B978-0-08-101975-7.00005-1 ↗
55. Rani V, Venkatesan J, Prabhu A (2020) Nanotherapeutics in glioma management: Advances and future perspectives. J Drug Deliv Sci Technol:101626.https://doi.org/10.1016/j.jddst.2020.10162610.1016/j.jddst.2020.101626 ↗
56. Rao CNR, Kulkarni GU, Thomas PJ, Edwards PP (2002) Size-dependent chemistry: properties of nanocrystals. Chem Eur J 8:28–35. https://doi.org/10.1002/1521-3765(20020104)8:1%3c28::AID-CHEM28%3e3.0.CO;2-B10.1002/1521-3765(20020104)8:1<28::AID-CHEM28>3.0.CO;2-B ↗
57. Ren H, Zhu C, Li Z, Yang W, Song E (2014) Emodin-loaded magnesium silicate hollow nanocarriers for anti-angiogenesis treatment through inhibiting VEGF. Int J Mol Sci 15:16936–16948. https://doi.org/10.3390/ijms15091693610.3390/ijms150916936 ↗
58. Shen N, Zhang R, Zhang HR, Luo HY, Shen W, Gao X, Guo DZ, Shen J (2018) Inhibition of retinal angiogenesis by gold nanoparticles via inducing autophagy. Int J Ophthalmol 8:1269. https://doi.org/10.18240/ijo.2018.08.0410.18240/ijo.2018.08.04 ↗
59. Sherlock SP, Dai H (2011) Multifunctional FeCo-graphitic carbon nanocrystals for combined imaging, drug delivery and tumor-specific photothermal therapy in mice. Nano Res 4:1248–1260. https://doi.org/10.1007/s12274-011-0176-z10.1007/s12274-011-0176-z ↗
60. Sobczak-Kupiec A, Malina D, Zimowska M, Wzorek Z (2011) Characterization of gold nanoparticles for various medical application. Dig J Nanomater Bios 803:8
61. Soni N, Jyoti K, Jain UK, Katyal A, Chandra R, Madan J (2017) Noscapinoids bearing silver nanocrystals augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in B16F1, mouse melanoma skin cancer cells. Biomed Pharmacother 90:906–913. https://doi.org/10.1016/j.biopha.2017.04.04210.1016/j.biopha.2017.04.042 ↗
62. Sridhar SS, Shepherd FA (2003) Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer. Lung Cancer 42:81–91. https://doi.org/10.1016/S0169-5002(03)00308-810.1016/S0169-5002(03)00308-8 ↗
63. Sun X, Huang X, Guo J, Zhu W, Ding Y, Niu G, Wang A, Kiesewetter DO, Wang ZL, Sun S, Chen X (2014) Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging. J Am Chem Soc 136:1706–1709. https://doi.org/10.1021/ja410438n10.1021/ja410438n ↗
64. Sztandera K, Gorzkiewicz M, Klajnert-Maculewicz B (2018) Gold nanoparticles in cancer treatment. Mol Pharm 1:1–23. https://doi.org/10.1021/acs.molpharmaceut.8b0081010.1021/acs.molpharmaceut.8b00810 ↗
65. Tahergorabi Z, Khazaei M (2012) A review on angiogenesis and its assays. Iran J Basic Med 15:1110
66. Talekar M, Ganta S, Amiji M, Jamieson S, Kendall J, Denny WA, Garg S (2013) Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy. Int J Pharm 450:278–289. https://doi.org/10.1016/j.ijpharm.2013.04.05710.1016/j.ijpharm.2013.04.057 ↗
67. Thakur PS, Sheokand S, Bansal AK (2019) Factors affecting crystallization kinetics of fenofibrate and its implications for the generation of nanocrystalline solid dispersions via spray drying. Cryst Growth Des 8:4417–4428. https://doi.org/10.1021/acs.cgd.9b0020310.1021/acs.cgd.9b00203 ↗
68. Wang D, Xu Z, Yu H, Chen X, Feng B, Cui Z, Lin B, Yin Q, Zhang Z, Chen C, Wang J (2014) Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods. Biomaterials 35:8374–8384. https://doi.org/10.1016/j.biomaterials.2014.05.09410.1016/j.biomaterials.2014.05.094 ↗
69. Wang H, Zhu W, Huang Y, Li Z, Jiang Y, Xie Q (2017) Facile encapsulation of hydroxycamptothecin nanocrystals into zein-based nanocomplexes for active targeting in drug delivery and cell imaging. Acta Biomater 61:88–100. https://doi.org/10.1016/j.actbio.2017.04.01710.1016/j.actbio.2017.04.017 ↗
70. Waterhouse DN, Yapp D, Verreault M, Anantha M, Sutherland B, Bally MB (2011) Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy. Nanomedecine 6:1645–1654. https://doi.org/10.2217/nnm.11.14010.2217/nnm.11.140 ↗
71. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. New Engl J Med 324:1–8. https://doi.org/10.1056/NEJM19910103324010110.1056/NEJM199101033240101 ↗
72. Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17:1359. https://doi.org/10.1038/nm.253710.1038/nm.2537 ↗
73. Xie J, Zhang Y, Yan C, Song L, Wen S, Zang F, Chen G, Ding Q, Yan C, Gu N (2014) High-performance PEGylated Mn–Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics. Biomaterials 35:9126–9136. https://doi.org/10.1016/j.biomaterials.2014.07.01910.1016/j.biomaterials.2014.07.019 ↗
74. Yadav L, Puri N, Rastogi V, Satpute P, Sharma V (2015) Tumor angiogenesis and angiogenic inhibitors: a review. JCDR 9:1. https://doi.org/10.7860/JCDR/2015/12016.613510.7860/JCDR/2015/12016.6135 ↗
75. Yang X, Liu Y, Zhao Y, Han M, Guo Y, Kuang H, Wang X (2016) A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Int J Nanomed 11:2979. https://doi.org/10.2147/IJN.S10272610.2147/IJN.S102726 ↗
76. Yi L, Ye L, Wei W (2016) Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B 6:106–113. https://doi.org/10.1016/j.apsb.2015.11.00510.1016/j.apsb.2015.11.005 ↗
77. Yokoyama Y, Ramakrishnan S (2007) Binding of endostatin to human ovarian cancer cells inhibits cell attachment. Int J Cancer 121:2402–2409. https://doi.org/10.1002/ijc.2293510.1002/ijc.22935 ↗
78. Yoo SY, Kwon SM (2013) Angiogenesis and its therapeutic opportunities. Mediat Inflamm. https://doi.org/10.1155/2013/12717010.1155/2013/127170 ↗
79. Zhang H, Hollis CP, Zhang Q, Li T (2011) Preparation and antitumor study of camptothecin nanocrystals. Int J Pharm 415:293–300. https://doi.org/10.1016/j.ijpharm.2011.05.07510.1016/j.ijpharm.2011.05.075 ↗
80. Zhong H, Mirkovic T, Scholes GD (2011) Nanocrystal synthesis. In: Andrews DL, Scholes GD, Wiederrecht GP (eds) Comprehensive nanoscience and technology. Elsevier Inc, pp 153–20110.1016/B978-0-12-374396-1.00051-9 ↗